Developing a new device or drug treatment is near impossible without the capital to support it.
How can innovators in healthcare present their ideas to investors in a way that triggers their interest and, ultimately, their financial backing?
In this episode, host Shravani Durbhakula, MD, dives into this question alongside Ali Behbahani, MD, of New Enterprise Associates, one of the top venture capitalist firms for tech in healthcare. With his combined experience in business and medicine, Dr. Behbahani lays out what investors in healthcare innovation value most in the development of a successful business plan.
Tune in to hear:
Developing a new device or drug treatment is near impossible without the capital to support it.
How can innovators in healthcare present their ideas to investors in a way that triggers their interest and, ultimately, their financial backing?
In this episode, host Shravani Durbhakula, MD, dives into this question alongside Ali Behbahani, MD, of New Enterprise Associates, one of the top venture capitalist firms for tech in healthcare. With his combined experience in business and medicine, Dr. Behbahani lays out what investors in healthcare innovation value most in the development of a successful business plan.
Tune in to hear: